| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2021-09-14 15:47:32 UTC |
|---|
| HMDB ID | HMDB0015009 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Terbutaline |
|---|
| Description | Terbutaline is only found in individuals that have used or taken this drug. It is a selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic. [PubChem]The pharmacologic effects of terbutaline are at least in part attributable to stimulation through beta-adrenergic receptors of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic- 3',5'- adenosine monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells. |
|---|
| Structure | CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 InChI=1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3 |
|---|
| Synonyms | | Value | Source |
|---|
| Terbutalina | ChEBI | | Terbutalinum | ChEBI | | Asthmasian | Kegg | | Terbutalin | HMDB | | Terbutaline sulfate | HMDB | | Alpharma brand OF terbutaline sulfate | HMDB | | Asthmoprotect | HMDB | | AstraZeneca brand OF terbutaline sulfate | HMDB | | Butalitab | HMDB | | Kendrick brand OF terbutaline sulfate | HMDB | | Terbul | HMDB | | Terbutalin stada | HMDB | | CT-Arzneimittel brand OF terbutaline sulfate | HMDB | | AstraZeneca brand OF terbutaline | HMDB | | Brethaire | HMDB | | Brethine | HMDB | | Hexal brand OF terbutaline sulfate | HMDB | | Hoechst brand OF terbutaline sulfate | HMDB | | Lagap brand OF terbutaline sulfate | HMDB | | Lindopharm brand OF terbutaline sulfate | HMDB | | Monovent | HMDB | | Novartis brand OF terbutaline sulfate | HMDB | | Stadapharm brand OF terbutaline sulfate | HMDB | | Terbutalin al | HMDB | | Terbutalin ratiopharm | HMDB | | Terbutalin-ratiopharm | HMDB | | Terbutaline astrazeneca brand | HMDB | | CT Arzneimittel brand OF terbutaline sulfate | HMDB | | Azupharma brand OF terbutaline sulfate | HMDB | | Bricanyl | HMDB | | Bricanyl sa | HMDB | | Butaliret | HMDB | | Contimit | HMDB | | Dermapharm brand OF terbutaline sulfate | HMDB | | Tedipulmo | HMDB | | Terbasmin | HMDB | | Pharma-stern brand OF terbutaline sulfate | HMDB | | Ratiopharm brand OF terbutaline sulfate | HMDB | | Terbutalin von CT | HMDB | | Aliud brand OF terbutaline sulfate | HMDB | | Arubendol | HMDB | | Estedi brand OF terbutaline sulfate | HMDB | | Fatol brand OF terbutaline sulfate | HMDB | | Taziken | HMDB | | Terbuturmant | HMDB |
|
|---|
| Chemical Formula | C12H19NO3 |
|---|
| Average Molecular Weight | 225.2842 |
|---|
| Monoisotopic Molecular Weight | 225.136493479 |
|---|
| IUPAC Name | 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol |
|---|
| Traditional Name | terbutaline |
|---|
| CAS Registry Number | 23031-25-6 |
|---|
| SMILES | CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 |
|---|
| InChI Identifier | InChI=1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3 |
|---|
| InChI Key | XWTYSIMOBUGWOL-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as resorcinols. Resorcinols are compounds containing a resorcinol moiety, which is a benzene ring bearing two hydroxyl groups at positions 1 and 3. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Phenols |
|---|
| Sub Class | Benzenediols |
|---|
| Direct Parent | Resorcinols |
|---|
| Alternative Parents | |
|---|
| Substituents | - Resorcinol
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Monocyclic benzene moiety
- 1,2-aminoalcohol
- Secondary alcohol
- Secondary amine
- Secondary aliphatic amine
- Aromatic alcohol
- Alcohol
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Amine
- Organopnictogen compound
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 119 - 122 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 5.84 g/L | Not Available | | LogP | 1.4 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.65 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.1152 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.82 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 183.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Terbutaline,1TMS,isomer #1 | CC(C)(C)NCC(O[Si](C)(C)C)C1=CC(O)=CC(O)=C1 | 2062.1 | Semi standard non polar | 33892256 | | Terbutaline,1TMS,isomer #2 | CC(C)(C)NCC(O)C1=CC(O)=CC(O[Si](C)(C)C)=C1 | 2056.3 | Semi standard non polar | 33892256 | | Terbutaline,1TMS,isomer #3 | CC(C)(C)N(CC(O)C1=CC(O)=CC(O)=C1)[Si](C)(C)C | 2228.3 | Semi standard non polar | 33892256 | | Terbutaline,2TMS,isomer #1 | CC(C)(C)NCC(O[Si](C)(C)C)C1=CC(O)=CC(O[Si](C)(C)C)=C1 | 1959.3 | Semi standard non polar | 33892256 | | Terbutaline,2TMS,isomer #2 | CC(C)(C)N(CC(O[Si](C)(C)C)C1=CC(O)=CC(O)=C1)[Si](C)(C)C | 2246.6 | Semi standard non polar | 33892256 | | Terbutaline,2TMS,isomer #3 | CC(C)(C)NCC(O)C1=CC(O[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1 | 1975.5 | Semi standard non polar | 33892256 | | Terbutaline,2TMS,isomer #4 | CC(C)(C)N(CC(O)C1=CC(O)=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2169.8 | Semi standard non polar | 33892256 | | Terbutaline,3TMS,isomer #1 | CC(C)(C)NCC(O[Si](C)(C)C)C1=CC(O[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1 | 1876.8 | Semi standard non polar | 33892256 | | Terbutaline,3TMS,isomer #2 | CC(C)(C)N(CC(O[Si](C)(C)C)C1=CC(O)=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2180.7 | Semi standard non polar | 33892256 | | Terbutaline,3TMS,isomer #3 | CC(C)(C)N(CC(O)C1=CC(O[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2172.6 | Semi standard non polar | 33892256 | | Terbutaline,4TMS,isomer #1 | CC(C)(C)N(CC(O[Si](C)(C)C)C1=CC(O[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2206.4 | Semi standard non polar | 33892256 | | Terbutaline,4TMS,isomer #1 | CC(C)(C)N(CC(O[Si](C)(C)C)C1=CC(O[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2163.9 | Standard non polar | 33892256 | | Terbutaline,4TMS,isomer #1 | CC(C)(C)N(CC(O[Si](C)(C)C)C1=CC(O[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2018.9 | Standard polar | 33892256 | | Terbutaline,1TBDMS,isomer #1 | CC(C)(C)NCC(O[Si](C)(C)C(C)(C)C)C1=CC(O)=CC(O)=C1 | 2318.1 | Semi standard non polar | 33892256 | | Terbutaline,1TBDMS,isomer #2 | CC(C)(C)NCC(O)C1=CC(O)=CC(O[Si](C)(C)C(C)(C)C)=C1 | 2282.5 | Semi standard non polar | 33892256 | | Terbutaline,1TBDMS,isomer #3 | CC(C)(C)N(CC(O)C1=CC(O)=CC(O)=C1)[Si](C)(C)C(C)(C)C | 2471.6 | Semi standard non polar | 33892256 | | Terbutaline,2TBDMS,isomer #1 | CC(C)(C)NCC(O[Si](C)(C)C(C)(C)C)C1=CC(O)=CC(O[Si](C)(C)C(C)(C)C)=C1 | 2408.9 | Semi standard non polar | 33892256 | | Terbutaline,2TBDMS,isomer #2 | CC(C)(C)N(CC(O[Si](C)(C)C(C)(C)C)C1=CC(O)=CC(O)=C1)[Si](C)(C)C(C)(C)C | 2711.1 | Semi standard non polar | 33892256 | | Terbutaline,2TBDMS,isomer #3 | CC(C)(C)NCC(O)C1=CC(O[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1 | 2460.7 | Semi standard non polar | 33892256 | | Terbutaline,2TBDMS,isomer #4 | CC(C)(C)N(CC(O)C1=CC(O)=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2673.3 | Semi standard non polar | 33892256 | | Terbutaline,3TBDMS,isomer #1 | CC(C)(C)NCC(O[Si](C)(C)C(C)(C)C)C1=CC(O[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1 | 2599.1 | Semi standard non polar | 33892256 | | Terbutaline,3TBDMS,isomer #2 | CC(C)(C)N(CC(O[Si](C)(C)C(C)(C)C)C1=CC(O)=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2880.7 | Semi standard non polar | 33892256 | | Terbutaline,3TBDMS,isomer #3 | CC(C)(C)N(CC(O)C1=CC(O[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2894.8 | Semi standard non polar | 33892256 | | Terbutaline,4TBDMS,isomer #1 | CC(C)(C)N(CC(O[Si](C)(C)C(C)(C)C)C1=CC(O[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 3089.4 | Semi standard non polar | 33892256 | | Terbutaline,4TBDMS,isomer #1 | CC(C)(C)N(CC(O[Si](C)(C)C(C)(C)C)C1=CC(O[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2896.8 | Standard non polar | 33892256 | | Terbutaline,4TBDMS,isomer #1 | CC(C)(C)N(CC(O[Si](C)(C)C(C)(C)C)C1=CC(O[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2457.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-9600000000-883d61ad257dffc64a5d | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (3 TMS) - 70eV, Positive | splash10-0a4i-4009200000-9ae8a659f4d6ab038c42 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TBDMS_3_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TBDMS_3_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Terbutaline GC-MS (TBDMS_3_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QTOF , positive-QTOF | splash10-004i-0290000000-8c26dbc913131cf49bc4 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QTOF , positive-QTOF | splash10-0udi-0900000000-3148282c5452a80b16c3 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QTOF , positive-QTOF | splash10-0udi-0900000000-9122151a6e70e6f2b536 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QQ , positive-QTOF | splash10-004i-0090000000-aab7f309385309d8884b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QQ , positive-QTOF | splash10-0udi-0920000000-1e85cd2bf4a0358c22d7 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QQ , positive-QTOF | splash10-0udi-0900000000-82b70479a4e38921e06b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QQ , positive-QTOF | splash10-0a4i-2900000000-aff994ffd107ef3b6e71 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QQ , positive-QTOF | splash10-0a6r-7900000000-cfe77aa0133facea1c75 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-IT , positive-QTOF | splash10-0udi-0900000000-1a0ccd393797b19105a0 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QTOF , positive-QTOF | splash10-004i-0190000000-f9271bb736a512dbdbab | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QTOF , positive-QTOF | splash10-0udi-0900000000-a70c8697ca7633839444 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QTOF , positive-QTOF | splash10-0a6r-1900000000-4a9c0ddb9af4ce93b4ae | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QTOF , positive-QTOF | splash10-0a6r-6900000000-0cc68c4a50196d6ffab6 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline LC-ESI-QTOF , positive-QTOF | splash10-004i-9400000000-e1cec349ffb2fcd3ebe2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline 30V, Positive-QTOF | splash10-0a6r-1900000000-66b082864419c2ddb9d5 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline 20V, Positive-QTOF | splash10-0udi-0900000000-a70c8697ca7633839444 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline 40V, Positive-QTOF | splash10-0a6r-6900000000-0cc68c4a50196d6ffab6 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline 50V, Positive-QTOF | splash10-004i-9400000000-e1cec349ffb2fcd3ebe2 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Terbutaline 30V, Positive-QTOF | splash10-0a6r-1900000000-4a9c0ddb9af4ce93b4ae | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Terbutaline 10V, Positive-QTOF | splash10-0a6r-0290000000-9796f2ff21f424e4e05e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Terbutaline 20V, Positive-QTOF | splash10-0zg0-1940000000-233ca9ad582e2ad95cd5 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Terbutaline 40V, Positive-QTOF | splash10-0k9i-5900000000-92f8d44ebccabc74764f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Terbutaline 10V, Negative-QTOF | splash10-00di-1190000000-b64eabaa2feb653f341a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Terbutaline 20V, Negative-QTOF | splash10-05fr-4490000000-0e761dccb9282646875d | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Terbutaline 40V, Negative-QTOF | splash10-0abi-9800000000-c64d63f8e4a1c43cef38 | 2016-08-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Hochhaus G, Mollmann H: Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol. Int J Clin Pharmacol Ther Toxicol. 1992 Sep;30(9):342-62. [PubMed:1358833 ]
- Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O, et al.: Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991 Aug 8;325(6):388-92. [PubMed:2062329 ]
- Rhodes MC, Seidler FJ, Abdel-Rahman A, Tate CA, Nyska A, Rincavage HL, Slotkin TA: Terbutaline is a developmental neurotoxicant: effects on neuroproteins and morphology in cerebellum, hippocampus, and somatosensory cortex. J Pharmacol Exp Ther. 2004 Feb;308(2):529-37. Epub 2003 Nov 10. [PubMed:14610225 ]
|
|---|